Journal of agricultural and food chemistry

Dihydromyricetin May Reduce Reserpine-Induced Depression by Changing Gut Bacteria and Brain Communication

Updated

Abstract

Dihydromyricetin (DMY) improved depression-like behaviors in a rat model, showing potential for dietary use.

  • DMY reduced symptoms of anhedonia, behavioral despair, and cognitive dysfunction in the rat model.
  • Circulating pro-inflammatory cytokines and neuronal damage in the hippocampus were decreased with DMY treatment.
  • DMY restored gut microbial diversity and composition, affecting bile acid and short-chain fatty acid profiles.
  • Fecal microbiota transplantation from DMY-treated rats replicated the antidepressant-like effects and restored important microbial metabolites.
  • These findings indicate that DMY may influence depression-like behaviors by modulating gut microbiota and neuroinflammatory responses.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free